Serum adenosine deaminase activity and coronary artery disease: a retrospective case-control study based on 9929 participants.

Chao XuanQing-Wu TianShao-Yan ZhangHui LiTing-Ting TianPeng ZhaoKang YueYan-Yan LingGuo-Wei HeLi-Min Lun

Published in: Therapeutic advances in chronic disease (2019)

Serum ADA activity is significantly attenuated in patients with CAD, particularly in MI. We propose a mechanism by which the body maintains adenosine levels to protect the cardiovascular system in the event of CAD.

Keyphrases

coronary artery disease
percutaneous coronary intervention
cardiovascular events
coronary artery bypass grafting
protein kinase
heart failure
acute coronary syndrome
left ventricular
aortic valve